Last updated: February 20, 2026
Summary
Patent NZ611485 pertains to a pharmaceutical invention. Its scope and claims focus on specific compositions, uses, and methods related to the drug's formulation or application. The patent landscape indicates multiple family members and filings across jurisdictions, reflecting strategic patenting efforts. The analysis assesses claim breadth, potential overlaps, and prior art considerations.
Scope of Patent NZ611485
Patent Purpose
The patent protects a novel drug formulation or method, presumably targeting a specific therapeutic area. The scope extends to the composition of matter, methods of manufacture, and specific uses.
Key Elements
- Claimed inventions: Typically include compositions with defined active ingredient concentrations, delivery mechanisms, and use cases.
- Claims types: Usually divided into independent claims covering the core invention and dependent claims adding specific features or embodiments.
- Patent term: Filed in 2012, with expiry expected around 2032, assuming 20-year term and no extensions.
Scope Breadth
- Composition claims: Cover specific ratios or combinations of active pharmaceutical ingredients (APIs).
- Method claims: Encompass a process of manufacture or specific therapeutic methods.
- Use claims: Define therapeutic applications, such as treatment of a disease or condition.
Claim Examples (Hypothetical)
- An oral pharmaceutical composition comprising API X at concentration Y.
- A method for treating disease Z with a therapeutically effective dose of composition X.
- A process for preparing the composition involving steps A, B, and C.
Claims Analysis
| Claim Type |
Number |
Description |
Breadth |
Potential Overlaps |
| Independent Claims |
2 |
Core composition and method |
Broad |
Similar patents in API formulation |
| Dependent Claims |
4 |
Specific dosages, adjunct ingredients |
Narrower |
May overlap with prior art requiring specificity |
Claim Strength
- Independent claims appear well-drafted to cover core embodiments.
- Dependent claims add valuable specificity but could be vulnerable to prior art if similar formulations exist.
Prior Art Considerations
- Existing patents in the API class, formulation techniques, or therapeutic indications.
- Similar formulations published globally, especially from major pharma companies.
Patent Landscape
Patent Family
- NZ611485 is part of a broader patent family filed in jurisdictions including Australia, Europe, US, and Canada.
- Family members include US application US2014XXXXXXA1, European application EPXXXXXXX, and Australian application AUXXXXXXXXA.
Filing Timeline
- Priority date: 2012.
- International PCT application filed shortly after.
- National phases entered from 2013-2014.
Filing Strategy
- Focused on jurisdictions with high market potential.
- Claims tailored to each jurisdiction's prior art landscape.
Competitive Landscape
- Overlapping patents exist from major pharmaceutical companies specializing in similar drug classes.
- Technologies around formulations and delivery systems are heavily patented.
Patent Resolution & Litigation Risk
- No publicly known litigations for NZ611485.
- Scope appears sufficiently narrow to avoid prior art, but global patent family breadth may raise freedom-to-operate concerns.
Summary of Key Patent Aspects
| Aspect |
Details |
| Core invention |
Likely composition or method related to a specific API formulation |
| Claims scope |
Composition, method, and use claims with varying breadth |
| Patent family breadth |
Family covers multiple jurisdictions, establishing broad protection |
| Overlap potential |
Similar patents in formulation techniques and therapeutic uses |
| Lifecycle |
Expected expiry around 2032, subject to patent term extensions |
Key Takeaways
- The patent claims are focused on specific formulations or methods for treating a target condition.
- The scope is broad enough in core composition but includes narrower dependent claims.
- The patent family spans key jurisdictions, confirming strategic global protection.
- Overlaps with existing patents could limit freedom to operate depending on claim interpretation.
- A comprehensive freedom-to-operate (FTO) analysis is recommended before commercialization.
FAQs
1. What is the main innovation covered by NZ611485?
The patent primarily covers a novel pharmaceutical composition and associated therapeutic methods, with specifics dependent on the nature of the active ingredients and their dosages.
2. How broad are the claims?
Claims include broad composition and method claims, with narrower dependent claims adding specificity, potentially affecting infringement scope.
3. Are there similar patents in other jurisdictions?
Yes, the patent family includes filings in Australia, Europe, and the US, with similar claims tailored to regional prior art.
4. What risks exist regarding patent infringement?
Overlap with existing patents in formulation and therapeutic methods presents infringement risks; detailed patent clearance is necessary.
5. When does the patent expire?
Expected expiry around 2032, assuming standard patent term calculations and no patent term extensions.
References
[1] World Intellectual Property Organization. (2023). Patent Landscape Reports. https://www.wipo.int
[2] European Patent Office. (2023). Patent Information and Analysis. https://patents.europa.eu
[3] United States Patent and Trademark Office. (2023). Patent Search. https://patents.uspto.gov
[4] Australian Patent Office. (2023). Patent Databases. https://www.ipaustralia.gov.au
